Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Anuj Malik, MD, MS

Ascension St. John's Medical Center

Disclosure(s): Rigel Pharmaceuticals: Grant/Research Support

Poster(s):

1141 - Phase 3 Trial (in progress) of the SYK inhibitor Fostamatinib in Patients Hospitalized with COVID-19: Protocol and Study Implementation Updates
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET